• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation

	Advanced Biomed Inc. (ADVB)
	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014	Q2-CY2014	Q1-CY2014	Q4-CY2013
Balance Sheet Date		2025-Sep-30	2025-Jun-30	2025-Mar-31	2024-Dec-31
Fiscal Period		Q1-FY2026	Q4-FY2025	Q3-FY2025	Q2-FY2025
Close Price of Common Stock	0.38$	0.44$	0.70$	3.92$
Market Cap of Common Stock	8,136,640$	9,536,748$	15,126,360$
QoQ%	(14.68%)	(36.95%)
YoY%
Common Shares Outstanding	21,640,000	21,640,000	21,640,000	21,640,000	20,000,000	20,000,000	20,000,000	20,000,000	20,000,000
QoQ%	.00%	.00%	.00%	8.20%	.00%	.00%	.00%	.00%
YoY%	8.20%	8.20%	8.20%	8.20%	.00%
Price to Sales
Price to Earnings	-	-	-
Price to Book	2.71x	3.17x	4.35x
Total Revenue
QoQ%
YoY%
TTM
TTM_QoQ%
TTM_YoY%
Gross Margin
QoQ
YoY
Operating Income
QoQ%
YoY%
TTM
TTM_QoQ%
TTM_YoY%
Operating Margin
QoQ
YoY
Net Income		(386,901$)	(701,611$)	(1,383,874$)	(907,904$)	(265,580$)	(809,386$)	(1,056,231$)	(145,345$)
QoQ%		44.86%	49.30%	(52.43%)	(241.86%)	67.19%	23.37%	(626.71%)
YoY%		(45.68%)	13.32%	(31.02%)	(524.65%)
TTM		(3,380,290$)	(3,258,969$)	(3,366,744$)	(3,039,101$)	(2,276,542$)
TTM_QoQ%		(3.72%)	3.20%	(10.78%)	(33.50%)
TTM_YoY%		(48.48%)
Profit Margin
QoQ
YoY
Equity to Common Shareholders		3,004,124$	3,477,564$	4,129,783$	619,032$	1,093,830$	1,663,258$	(497,797$)	196,841$
QoQ		(473,440$)	(652,219$)	3,510,751$	(474,798$)	(569,428$)	2,161,055$	(694,638$)
QoQ%		(13.61%)	(15.79%)	567.14%	(43.41%)	(34.24%)	434.12%	(352.89%)
YoY		1,910,294$	1,814,306$	4,627,580$	422,191$
YoY%		174.64%	109.08%	929.61%	214.48%
Dividends Paid
Additional Paid-In Capital QoQ
Treasury Stock
QoQ
Goodwill
QoQ%
YoY%
Other Intangible Assets				20,325$	50,516$		118,998$
QoQ				(30,191$)
Amortization of Intangible Assets				30,191$	33,554$			31,899$	31,692$
Total Assets		6,242,970$	6,512,343$	8,287,598$	4,504,152$		4,460,247$
QoQ		(269,373$)	(1,775,255$)	3,783,446$
YoY			2,052,096$
Total Liabilities		3,238,846$	3,034,779$	4,157,815$	3,885,120$		2,796,989$
QoQ		204,067$	(1,123,036$)	272,695$
YoY			237,790$
Current Ratio		1.92x	2.09x	1.88x	.82x		1.12x
Total Current Assets		5,844,133$	6,032,571$	7,731,148$	3,138,891$		3,051,110$
QoQ		(188,438$)	(1,698,577$)	4,592,257$
Total Current Liabilities		3,044,952$	2,889,128$	4,113,343$	3,828,794$		2,732,460$
QoQ		155,824$	(1,224,215$)	284,549$
Debt to Asset Ratio		.52x	.47x	.50x	.86x		.63x
Long Term Debt
QoQ
YoY
Capital Lease Obligations		30,869$	41,690$	182,829$	290,027$		126,740$
Cash and Cash Equivalents
QoQ
YoY
Interest Expenses
Interest Income		448$	9,512$	(24$)	15,417$	10$	33,411$	104$	19,966$

Copy Table ✓